Immunotherapy for Infectious Diseases

298 Wallis and Johnson
77. Ellner JJ. Pleural fluid and peripheral blood lymphocyte function in tuberculosis. Ann
Intern Med 1978; 89:932–933.
78. Rossi GA, Balbi B, Manca F. Tuberculous pleural effusions. Evidence for selective presence
of PPD-specific T-lymphocytes at site of inflammation in the early phase of the infection.
Am Rev Respir Dis 1987; 136:575–579.
79. Vanham G, Toossi Z, Hirsch CS, et al. Examining a paradox in the pathogenesis of human
pulmonary tuberculosis: immune activation and suppression/anergy. Tuber Lung Dis
1997; 78:145–158.
80. Ellner JJ. Tuberculosis in the time of AIDS. The facts and the message. Chest 1990;
98:1051–1052.
81. Small PM, Schecter GF, Goodman PC, Sande MA, Chaisson RE, Hopewell PC. Treatment
of tuberculosis in patients with advanced human immunodeficiency virus infection. N
Engl J Med 1991; 324:289–294.
82. Wallis RS, Vjecha M, Amir Tahmasseb M, et al. Influence of tuberculosis on human
immunodeficiency virus (HIV-1): enhanced cytokine expression and elevated beta
2-microglobulin in HIV-1-associated tuberculosis. J Infect Dis 1993; 167:43–48.
83. Folks TM, Justement J, Kinter A, et al. Characterization of a promonocyte clone chronically
infected with HIV and inducible by 13-phorbol-12-myristate acetate. J Immunol
1988; 140:1117–1122.
84. Chun TW, Engel D, Mizell SB, Ehler LA, Fauci AS. Induction of HIV-1 replication in
latently infected CD4� T cells using a combination of cytokines [published erratum
appears in J Exp Med 1998 188:following 614]. J Exp Med 1998; 188:83–91.
85. Griffin GE, Leung K, Folks TM, Kunkel S, Nabel GJ. Induction of NF-kappa B during
monocyte differentiation is associated with activation of HIV-gene expression. Res Virol
1991; 142:233–238.
86. Potts BJ, Maury W, Martin MA. Replication of HIV-1 in primary monocyte cultures.
Virology 1990; 175:465–476.
87. Latham PS, Lewis AM, Varesio L, et al. Expression of human immunodeficiency virus
long terminal repeat in the human promonocyte cell line U937: effect of endotoxin and
cytokines. Cell Immunol 1990; 129:513–518.
88. Goletti D, Weissman D, Jackson RW, Collins F, Kinter A, Fauci AS. The in vitro induction
of human immunodeficiency virus (HIV) replication in purified protein derivativepositive
HIV-infected persons by recall antigen response to M. tuberculosis is the result
of a balance of the effects of endogenous interleukin-2 and proinflammatory and antiinflammatory
cytokines. J Infect Dis 1998; 177:1332–1338.
89. Kinter AL, Ostrowski M, Goletti D, et al. HIV replication in CD4� T cells of HIVinfected
individuals is regulated by a balance between the viral suppressive effects of
endogenous beta-chemokines and the viral inductive effects of other endogenous cytokines.
Proc Natl Acad Sci USA 1996; 93:14076–14081.
90. Zhang Y, Doerfler M, Lee TC, Guillemin B, Rom WN. Mechanisms of stimulation of
interleukin-1 beta and tumor necrosis factor-alpha by M. tuberculosis components. J Clin
Invest 1993; 91:2076–2083.
91. Zhang Y, Nakata K, Weiden M, Rom WN. M. tuberculosis enhances human immunodeficiency
virus-1 replication by transcriptional activation at the long terminal repeat. J Clin
Invest 1995; 95:2324–2331.
92. Lederman MM, Georges DL, Kusner DJ, Mudido P, Giam CZ, Toossi Z. M. tuberculosis
and its purified protein derivative activate expression of the human immunodeficiency
virus. J Acquir Immune Defic Syndr Hum Retrovirol 1994; 7:727–733.
93. Mudido P, Georges D, Jacobs G, Toossi Z, Ellner JJ, Lederman MM. Mycobacteria and
their products activate HIV expression. Int Conf AIDS. 1993; 9:325 (Abstract).
94. Nakata K, Rom WN, Honda Y, et al. M. tuberculosis enhances human immunodeficiency
virus-1 replication in the lung. Am J Respir Crit Care Med 1997; 155:996–1003.